In Czechia, many small hospitals are facing critical challenges due to the removal of internal medicine beds, a trend exacerbated by insufficient payments from health insurance companies. According to Michal Čarvaš, head of the Association of Czech and Moravian Hospitals, while large university hospitals receive adequate funding—for instance, around 95,000 CZK for treating urinary tract infections—regional hospitals receive about one-third less, which complicates their ability to maintain essential services. This discrepancy poses significant risks to the healthcare system especially as the population ages and the need for internal medicine services rises.

The issues plaguing smaller hospitals stem not only from financial constraints but also from the diminishing viability of various medical disciplines. Čarvaš indicated that internal medicine, traditionally a cornerstone of clinical care, is witnessing a decline in profitability, with many specialties struggling to remain sustainable. He highlights specific medical conditions such as sepsis, anemia, and heart failure as among the more financially stable procedures but notes that these are the very cases that local and county hospitals often manage. As these internal medicine beds close, effective treatment options for patients experiencing these conditions will increasingly be limited.

The crumbling infrastructure of internal medicine at regional hospitals serves as a stark indicator of the broader challenges faced by Czech healthcare. With the anticipated rise in demand driven by an aging population, the loss of internal medicine beds might lead to longer wait times and increased pressure on already burdened healthcare systems. If immediate corrective measures are not taken by policy makers, the situation could have severe implications for patient care and the overall efficacy of the country's healthcare system.